Tender detail

Supply of selective immunosuppressants containing ravulizumab

Summary

The Institute for Clinical and Experimental Medicine is procuring parenteral medicines containing ravulizumab (ATC L04AJ02) for patients with approved indications. The procurement consists of one lot, with an estimated value of CZK 352,260,000 and a planned duration of 48 months. The medicines will be supplied for use at the Institute in Prague.

Reference number
690837-2026
Buyer
Institut klinické a experimentální medicíny
Country
Czechia (CZE)
Procedure
Open procedure
CPV
33652300 Immunosuppressive agents
Deadline
2026-11-11
Status
Open
Contract subject
Supplies
Estimated value
352 260 000,00 CZK
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.